Astec LifeSciences Limited — Others, 23-04-2025: Statement of deviation/variation in use of Issue proceeds

The company has disclosed a statement detailing the deviation in the use of proceeds from the recent issue of shares. Key highlights include a shift in the allocation of funds, with a significant portion redirected to operational enhancements and strategic initiatives instead of the originally planned projects. This adjustment reflects management's adaptive strategy to bolster growth and operational efficiency. Investors may view this as a positive outlook for future performance; however, the deviation also introduces potential risks related to the execution of the revised plan.